Skip to main content

ITOC · iTonic Holdings Ltd · Metrics

Track ITOC — free
$0.25 +0.00 (+1.81%) At close · Oct 5
Market Cap
$7.19M
Shares
24.72M
Volume · Oct 5 206.92K Avg daily vol (3M) 791.63K

ITOC metrics

43 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.25
Market cap
$7.19M

Price action

20 metrics
Price change (1W)
-14.4%
Price change (30D)
-18.9%
Price change (3M)
-18.4%
Price change (6M)
-18.4%
Price change (YTD)
-40.9%
Price change (1Y)
-67.8%
Trailing year
Price change (5Y)
—
52-week high
$0.90
52-week low
$0.25
Change from 52-week high
-72.4%
Change from 52-week low
+0.0%
Annualized volatility
166.3%
Annualized volatility (3M)
78.4%
Beta
1.1
RSI (14D)
36.4
Price vs SMA 50
-14.5%
Price vs SMA 200
-28.7%
Avg volume (3M)
791,630
Relative volume
0.3
Average dollar volume
$245,698

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
24.72M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.2
reciprocal yield 85.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
62.6%
Operating margin
-991.7%
Trailing 12 months
Net margin
-974.7%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+16.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+26.1%
Year over year · more shares
Revenue CAGR (3Y)
-8.4%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-83.3%
Return on assets
-56.0%
Debt / equity
—
Current ratio
8.8
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
8.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.49M
Total assets
$9.10M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
12
13F filer change QoQ
+4
Institutional ownership
0.1%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
19 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1970544 CUSIP G71399102